PROSTATE-ASSOCIATED ANTIGENS AND VACCINE-BASED IMMUNOTHERAPY REGIMENS
The present disclosure provides (a) isolated immunogenic PAA polypeptides; (b) isolated nucleic acid molecules encoding immunogenic PAA polypeptides; (c) vaccine compositions comprising an immunogenic PAA polypeptide or an isolated nucleic acid molecule encoding an immunogenic PAA polypeptide; (d) m...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
22.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides (a) isolated immunogenic PAA polypeptides; (b) isolated nucleic acid molecules encoding immunogenic PAA polypeptides; (c) vaccine compositions comprising an immunogenic PAA polypeptide or an isolated nucleic acid molecule encoding an immunogenic PAA polypeptide; (d) methods relating to uses of the polypeptides, nucleic acid molecules, and compositions; and (e) vaccine-based immunotherapy regimens which involve co-administration of a vaccine in combination with an immune-suppressive-cell inhibitor and an immune-effector-cell enhancer.
La presente invención revela: (a) polipéptidos de PAA inmunógeno aislados; (b) moléculas aisladas de ácido nucleico que codifican péptidos PAA inmunógenos; (c) composiciones de vacuna que comprenden un polipéptido PAA inmunógeno o una molécula aislada de ácido nucleico que codifica un polipéptido PAA inmunógeno; (d) métodos relacionados con usos de los polipéptidos, moléculas de ácido nucleico, y composiciones; y (e) regimenes de inmunoterapia basados en vacunas que implican la coadministración de una vacuna en combinación con un inhibidor de células inmunosupresoras y un reforzador de células inmunoefectoras. |
---|---|
Bibliography: | Application Number: MX20140013366 |